Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details)

v3.21.2
Stockholders' Deficit (Details) - $ / shares
1 Months Ended 6 Months Ended 12 Months Ended
Apr. 06, 2020
Feb. 17, 2021
Jun. 30, 2021
Dec. 31, 2020
Jul. 01, 2017
Stockholders' Equity Note [Abstract]          
Common stock, shares authorized     200,000,000 200,000,000  
Common stock par value (in Dollars per share)     $ 0.001 $ 0.001  
Description of consulting exercised     employees and consultants exercised a total of 383,721 stock options and the Company received $119,000 in proceeds. A portion of these options were exercised early (prior to vesting), and as of June 30, 2021, 126,501 of the options remained unvested. Proceeds received related to the unvested options of $82,000 at June 30, 2021 were recorded in accrued liabilities on the accompanying balance sheets and will be reclassified to equity as vesting occurs, provided the employees and consultants continue to provide services to the Company. The vested portion of the exercises was 257,220 shares at June 30, 2021.    
Issued shares 348,837 1,767,442 33,263 33,263  
Share price (in Dollars per share)     $ 4.21 $ 4.21 $ 0.013
Investors exchange of shares       24,627  
Preferred stock, shares authorized     10,000,000 10,000,000  
Preferred stock, par value (in Dollars per share)     $ 0.001 $ 0.001